uBiome Overview

  • Founded
  • 2012
Founded
  • Status
  • Out of Business
  • Employees
  • 100
Employees
  • Latest Deal Type
  • Liquidation

uBiome General Information

Description

Provider of sequencing-based clinical microbiome tests designed to gather, analyze and translate data about the human microbiome. The company combines precision sequencing with machine learning and artificial intelligence to advance the science of the microbiome and make it useful, enabling doctors to get the accurate and required result to treat their patients and patients to take greater and better care of their health.

Contact Information

Website
www.ubiome.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 360 Langton Street
  • San Francisco, CA 94103
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

uBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation 01-Oct-2019 00000 Completed Bankruptcy: Liquidation
10. Later Stage VC (Series C) 21-Sep-2018 0000 00000 00000 Completed Generating Revenue
9. Early Stage VC (Series B) 29-Nov-2016 000.00 000.00 0000 Completed Generating Revenue
8. Accelerator/Incubator 24-Jun-2015 00.000 Completed Startup
7. Product Crowdfunding 25-Apr-2015 000.00 00.000 Completed Startup
6. Accelerator/Incubator 19-Aug-2014 00000 00.000 00.000 Completed Startup
5. Early Stage VC (Series A) 01-Jun-2014 00.00 00.00 000.00 Completed Startup
4. Seed Round 29-Oct-2013 Completed Startup
3. Product Crowdfunding 30-Sep-2013 $350K Completed Startup
2. Product Crowdfunding 19-Feb-2013 $361K Completed Startup
To view uBiome’s complete valuation and funding history, request access »

uBiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 17,565,505 $0.000100 $0.07 $1.14 $1.14 1x $1.14 19.18%
Series A 18,111,922 $0.000100 $0.02 $0.34 $0.34 1x $0.34 19.78%
To view uBiome’s complete cap table history, request access »

uBiome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of sequencing-based clinical microbiome tests designed to gather, analyze and translate data about the human mi
Drug Discovery
San Francisco, CA
100 As of 2019
00000
000000000000 00000

000000 0

e eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offici
0000 000000000
Brisbane, CA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

00000000

onsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nul
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

uBiome Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Second Genome Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
00000 (0000 000000 Formerly VC-backed Somerville, MA 000 00000 00000000 00000
00000000 Venture Capital-Backed Paris, France 00 00000 00000000000 00000
0000000000 Venture Capital-Backed Cambridge, MA 00000 00000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

uBiome Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial